Treatment failure in ovarian cancer is associated with drug-induced activation of HMGB1-mediated autophagy and with the inhibition of senescence, and Nac1 plays an essential role in both of these processes [12,13]. The gene discussed is NACC1; the disease is ovarian carcinoma.